CompletedNot Applicable

Trigonal vs Non Trigonal Botox Injection in OAB.

80 participantsStarted 2015-06-14

Plain-language summary

The investigators attend to conduct a prospective randomized study to assess safety and efficacy of trigonal-involved vs. trigonal-sparing botox injection technique, quality of life measurement and post-injection anticholinergics use efficacy. Assessing safety by identification of side effects like constipation, urine retention....etc. efficacy is measured using Over Active Bladder Symptoms Score(OABSS) and urodynamics measures after 6 months follow up.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with idiopathic OAB refractory to treatment with antimuscarinics for 2 months or intolerable side effects of antimuscrinics Exclusion Criteria: * Patients who have any of the following were excluded: * Age less than 18 year old. * Neurogenic detrusor overactivity. * Evidence of obstructed flow in absence of prolapse. * Mixed urinary incontinence * Associated urethral pathology, e.g. Urethral diverticulum * Associated bladder pathology e.g. Fistula. * Active urinary tract infection as evidenced by positive urine culture.

What they're measuring

efficacy of Botox injections of the bladder treating OAB using Over active bladder Symptoms score (OABSS).OABSS total score is 15.more score means more symptoms.it is divided into:1-5 &6-10&11-15 means mild &moderate&sever symptoms respectively.

Timeframe: 3 months

Trial details

NCT IDNCT03533062

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-10-30

View on ClinicalTrials.gov More Urologic Diseases trials